These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2. Ekbom T; Linjer E; Hedner T; Lanke J; De Faire U; Wester PO; Dahlöf B; Scherstén B Blood Press; 2004; 13(3):137-41. PubMed ID: 15223721 [TBL] [Abstract][Full Text] [Related]
25. The cardiovascular effect of vasopressin in relation to its plasma concentration in man and its relevance to high blood pressure. Khokhar AM; Slater JD; Ma J; Ramage CM Clin Endocrinol (Oxf); 1980 Sep; 13(3):259-66. PubMed ID: 7214720 [TBL] [Abstract][Full Text] [Related]
26. Association between cardiovascular outcomes and antihypertensive drug treatment in older women. Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916 [TBL] [Abstract][Full Text] [Related]
27. β-Blocker withdrawal is preferable for accurate interpretation of the aldosterone-renin ratio in chronically treated hypertension. Browne GA; Griffin TP; O'Shea PM; Dennedy MC Clin Endocrinol (Oxf); 2016 Mar; 84(3):325-31. PubMed ID: 26300226 [TBL] [Abstract][Full Text] [Related]
28. Trends in antihypertensive treatment--lessons from the National Acute Stroke Israeli (NASIS) registry. Koifman E; Tanne D; Molshatzki N; Leibowitz A; Grossman E Blood Press; 2014 Oct; 23(5):262-9. PubMed ID: 24483945 [TBL] [Abstract][Full Text] [Related]
29. Increased plasma vasopressin in low renin essential hypertension. Os I; Kjeldsen SE; Skjøtø J; Westheim A; Lande K; Aakesson I; Frederichsen P; Leren P; Hjermann I; Eide IK Hypertension; 1986 Jun; 8(6):506-13. PubMed ID: 2872161 [TBL] [Abstract][Full Text] [Related]
30. Association of angiotensin II type 1 receptor polymorphism with resistant essential hypertension. Szombathy T; Szalai C; Katalin B; Palicz T; Romics L; Császár A Clin Chim Acta; 1998 Jan; 269(1):91-100. PubMed ID: 9498106 [TBL] [Abstract][Full Text] [Related]
31. The influence of the alpha-adducin G460W polymorphism and angiotensinogen M235T polymorphism on antihypertensive medication and blood pressure. Schelleman H; Klungel OH; Witteman JC; Hofman A; van Duijn CM; de Boer A; Stricker BH Eur J Hum Genet; 2006 Jul; 14(7):860-6. PubMed ID: 16724011 [TBL] [Abstract][Full Text] [Related]
32. Sex differences in the endocrine predictors of essential hypertension. Vasopressin versus renin. Cowley AW; Skelton MM; Velasquez MT Hypertension; 1985; 7(3 Pt 2):I151-60. PubMed ID: 3888837 [TBL] [Abstract][Full Text] [Related]
33. [Assessment of antihypertensive monotherapies effectiveness by home blood pressure self-measurement in hypertensive patients]. Hanon O; Laroche P; Vidal JS; Pannier B; Postel-Vinay N; Vaisse B; Girerd X Ann Cardiol Angeiol (Paris); 2012 Jun; 61(3):218-23. PubMed ID: 22695025 [TBL] [Abstract][Full Text] [Related]
34. Blood pressure maintenance in awake dehydrated rats: renin, vasopressin, and sympathetic activity. Burnier M; Biollaz J; Brunner DB; Brunner HR Am J Physiol; 1983 Aug; 245(2):H203-9. PubMed ID: 6309021 [TBL] [Abstract][Full Text] [Related]
35. Vascular effects of arginine vasopressin, angiotensin II, and norepinephrine in adrenal insufficiency. Ishikawa S; Schrier RW Am J Physiol; 1984 Jan; 246(1 Pt 2):H104-13. PubMed ID: 6364835 [TBL] [Abstract][Full Text] [Related]
36. Effects of the lercanidipine-enalapril combination vs. the corresponding monotherapies on home blood pressure in hypertension: evidence from a large database. Mancia G; Omboni S; Chazova I; Coca A; Girerd X; Haller H; Parati G; Pauletto P; Pupek-Musialik D; Svyshchenko Y; J Hypertens; 2016 Jan; 34(1):139-48. PubMed ID: 26630216 [TBL] [Abstract][Full Text] [Related]
37. Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug. Ohta Y; Tsuchihashi T; Onaka U; Eto K; Ueno M Hypertens Res; 2007 Apr; 30(4):301-6. PubMed ID: 17541208 [TBL] [Abstract][Full Text] [Related]
38. Modulation of genetic hypertension by short-term AVP V1A or V2 receptor antagonism in young SHR. Naitoh M; Burrell LM; Risvanis J; Aldred KL; Rockell MD; Johnston CI; Phillips PA Am J Physiol; 1997 Feb; 272(2 Pt 2):F229-34. PubMed ID: 9124400 [TBL] [Abstract][Full Text] [Related]
39. Association between a polymorphism in the G protein beta3 subunit gene and lower renin and elevated diastolic blood pressure levels. Schunkert H; Hense HW; Döring A; Riegger GA; Siffert W Hypertension; 1998 Sep; 32(3):510-3. PubMed ID: 9740618 [TBL] [Abstract][Full Text] [Related]
40. Effect of single-administration captopril on plasma and urinary vasopressin in normotensive subjects and patients with essential hypertension and primary aldosteronism. Tsuchihashi T; Takishita S; Muratani H; Ueno M; Tomita Y; Kimura Y; Nakao Y; Fujishima M Jpn Circ J; 1989 Dec; 53(12):1473-80. PubMed ID: 2698964 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]